These emerging treatments , including Rybelsus, belong to a category of drugs called GLP-1 mimics . Primarily intended for controlling diabetes mellitus , they operate by assisting the organism to secrete sufficient insulin and limiting high glucose levels. Additionally , their capacity to encour